Arrowhead Pharmaceuticals ARWR
NASDAQ ARWR
$64.31 -0.48 (-0.74%)
As of: Oct 2, 2026 · 2:30 PM EDT

Arrowhead Pharmaceuticals (ARWR) Accumulated Expenses (2010 - 2026)

Updated

Arrowhead Pharmaceuticals (ARWR) reported Accumulated Expenses of $86.17 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 32.9% from $64.82 million a year earlier and up 12.5% from the prior quarter.

Analysis

Arrowhead Pharmaceuticals (ARWR) Accumulated Expenses (2010 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Arrowhead Pharmaceuticals posted Accumulated Expenses of $90.42 million, up 43.5% from FY2024.

  • Accumulated Expenses has a five-year compound annual growth rate of 75.8% (FY2020 to FY2025).
  • By fiscal year, Accumulated Expenses came in at $63.02 million in FY2024 (+58.5%), $39.76 million in FY2023 (-15.1%), $46.86 million in FY2022 (+234.7%) and $14 million in FY2021 (+159.8%).
  • Five-year quarterly Accumulated Expenses spans a low of $14 million in fiscal Q4 2021 and a high of $130.08 million in fiscal Q1 2026.
  • Year over year, Accumulated Expenses gained in seven of the last eight quarters, with growth averaging 53.3%.
  • The high point for year-over-year Accumulated Expenses in five years was fiscal Q4 2022 (growth of 234.7%); the low point was fiscal Q4 2023 (a decline of 15.1%).
  • Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $76.59 million (Q2 2026), $130.08 million (Q1 2026) and $90.42 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Arrowhead Pharmaceuticals 9.24 Bn 4.02 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 86.17 Mn
Mar 31, 2026 76.59 Mn
Dec 31, 2025 130.08 Mn
Sep 30, 2025 90.42 Mn
Jun 30, 2025 64.82 Mn
Mar 31, 2025 78.45 Mn
Dec 31, 2024 59.40 Mn
Sep 30, 2024 63.02 Mn
Jun 30, 2024 47.90 Mn
Mar 31, 2024 37.06 Mn
Dec 31, 2023 46.60 Mn
Sep 30, 2023 39.76 Mn
Jun 30, 2023 38.19 Mn
Mar 31, 2023 39.55 Mn
Dec 31, 2022 48.17 Mn
Sep 30, 2022 46.86 Mn
Jun 30, 2022 32.50 Mn
Mar 31, 2022 23.71 Mn
Dec 31, 2021 18.52 Mn
Sep 30, 2021 14.00 Mn
API Access

Arrowhead Pharmaceuticals Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ARWR&period=max&api_key=YOUR_API_KEY